Imatinib: A Review of its Use in the Management of Gastrointestinal Stromal Tumours

Author： Siddiqui M. Asif A.   Scott Lesley J.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.5, 2007-01, pp. : 805-820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Imatinib Mesylate: In the Treatment of Gastrointestinal Stromal Tumours

By Croom K.F.   Perry C.M.  

Drugs, Vol. 63, Iss. 5, 2003-01 ,pp. : 513-522

Adis International

Access to resources Recommend Favorite

Treatment of gastrointestinal stromal tumours: imatinib, sunitinib – and then?

By Nilsson Bengt   Nilsson Ola   Ahlman Håkan  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 457-468

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Imatinib Mesylate in the Treatment of Advanced Gastrointestinal Stromal Tumours

By Huse Daniel M.  

Clinical Drug Investigation, Vol. 27, Iss. 2, 2007-01 ,pp. : 85-93

Adis International

Access to resources Recommend Favorite

A Benefit-Risk Assessment of Imatinib in Chronic Myeloid Leukaemia and Gastrointestinal Stromal Tumours

By Wolf Dominik  

Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. : 1001-1015

Adis International

Access to resources Recommend Favorite

Pharmacotherapy of gastrointestinal stromal tumours

By Eisenberg Burton L   von Mehren Margaret  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 869-874

Informa Healthcare

Access to resources Recommend Favorite